Bio Equivalency test scandals curbs new product registrations.
Published: 2006-05-24 06:59:00
Updated: 2006-05-24 06:59:00
The bio equivalency test manipulation scandal has made a critical adverse impact to the drug registration, and the new registration of non-prescription drugs still kept standing still, which may aggravate more OTC market recession.
The KFDA reported that 400 drugs were registered from Jan. to...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
